BROSSARD, Quebec, Nov. 12, 2024 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A) a pioneer in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce the cross-listing of the Corporation’s subordinate common shares on the Frankfurt Stock Exchange (“FWB”) under the trading symbol “4D4A”. FWB is the largest of Germany’s seven stock exchanges. It facilitates advanced electronic trading, settlement and information systems and enables cross-border trading for international investors.
In addition to the FWB, the…
